Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8368
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorGoudevenos, J. A.en
dc.date.accessioned2015-11-24T16:41:07Z-
dc.date.available2015-11-24T16:41:07Z-
dc.identifier.issn0953-7104-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8368-
dc.rightsDefault Licence-
dc.subjectacute coronary syndromesen
dc.subjectclopidogrelen
dc.subjectplateletsen
dc.subjectstatinsen
dc.subjectacute coronary syndromesen
dc.subjectflow-cytometryen
dc.subjectatorvastatinen
dc.titleLipophilic statins do not affect the antiplatelet potency of clopidogrelen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDoi 10.1080/09537100500124525-
heal.identifier.secondary<Go to ISI>://000230428600014-
heal.identifier.secondaryhttp://informahealthcare.com/doi/abs/10.1080/09537100500124525-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2005-
heal.abstractThis letter to the editor discusses the results of the recently published study by Smith et al. which demonstrated that lipophilic statins metabolized through the cytochrome P-450 isoform 3A4 (CYP3A4) do not influence the antiplatelet effectiveness of clopidogrel in patients undergoing elective percutaneous coronary intervention. These results as well as those of other recent studies suggest that there is no adverse interaction between clopidogrel and CYP3A4-metabolized statins, during the maintenance phase of therapy (i.e., 2 or more days after the drug co-administration) either at the platelet or at the clinical level.en
heal.journalNamePlateletsen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons